Tandem Diabetes Care (TNDM) Equity Ratio (2013 - 2026)

Tandem Diabetes Care has reported Equity Ratio for 14 years, with the latest figure at 0.11 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio fell 31.83% year-over-year to 0.11; the trailing twelve-month figure through Mar 2026 stood at 0.11 (down 31.83% YoY), and the FY2025 full-year result was 0.18, down 35.23% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.11, down from 0.18 in the prior quarter.
• The five-year high for Equity Ratio was 0.43 in Q2 2022, with the low at 0.11 in Q1 2026.
• Historically, Equity Ratio has averaged 0.28 across 5 years, with a median of 0.27 in 2024.
• Annual changes were most pronounced in 2022 — Equity Ratio climbed 3.68% — and 2025, when it sank 38.99%.
• Tandem Diabetes Care's Equity Ratio stood at 0.42 in 2022, then declined by 21.22% to 0.33 in 2023, then declined by 17.41% to 0.27 in 2024, then slumped by 35.23% to 0.18 in 2025, then slumped by 34.82% to 0.11 in 2026.
• The last three Equity Ratio figures came in at 0.11 (Q1 2026), 0.18 (Q4 2025), and 0.15 (Q3 2025), per Business Quant data.